Unfruitful: Eating more produce will not cure, stop prostate cancer

byUniversity of California - San DiegoMicrograph showing prostatic acinar adenocarcinoma (the most common form of prostate cancer) Credit: Wikipedia,CC BY-SA 3.0National guidelines recomme

Updated on: December 22,2023 19

Unfruitful: Eating more produce will not cure, stop prostate cancer

byUniversity of California - San DiegoMicrograph showing prostatic acinar adenocarcinoma (the most common form of prostate cancer) Credit: Wikipedia,CC BY-SA 3.0National guidelines recomme

Updated on:December 22,2023 19

Not all patients want faster cancer drug approvals without certainty they work

byLondon School of EconomicsCredit: Pixabay/CC0 Public DomainPatients with cancer could be willing to wait for greater certainty of the benefit of new cancer drugs before they are approved by th

Updated on: November 29,2024 0

Not all patients want faster cancer drug approvals without certainty they work

byLondon School of EconomicsCredit: Pixabay/CC0 Public DomainPatients with cancer could be willing to wait for greater certainty of the benefit of new cancer drugs before they are approved by th

Updated on:November 29,2024 0

Colon cancer is being spotted in younger people, and at later stages

by Steven ReinbergColon cancer continues to rise among younger U.S. adults, with the American Cancer Society reporting a doubling of cases in people younger than 55 in about 25 years.Also, significant

Updated on: December 26,2023 8

Colon cancer is being spotted in younger people, and at later stages

by Steven ReinbergColon cancer continues to rise among younger U.S. adults, with the American Cancer Society reporting a doubling of cases in people younger than 55 in about 25 years.Also, significant

Updated on:December 26,2023 8

Barriers to early clinical trial access for adolescents and young adults still exist

byEuropean Society for Medical OncologyYoung cancer patients at the crossroads of childhood and adulthood seem to be stuck in a treatment impasse. A study to be presented at the ESMO 2018 Congre

Updated on: December 18,2023 14

Barriers to early clinical trial access for adolescents and young adults still exist

byEuropean Society for Medical OncologyYoung cancer patients at the crossroads of childhood and adulthood seem to be stuck in a treatment impasse. A study to be presented at the ESMO 2018 Congre

Updated on:December 18,2023 14

How optoacoustic imaging plays a role in assessing the success of breast cancer surgery

byAgency for Science, Technology and Research (A*STAR), SingaporeEquipment set-up. (A) Schematic of the handheld US-OT probe placed in heavy water tank on the specimen. The probe is then moved s

Updated on: December 23,2023 9

How optoacoustic imaging plays a role in assessing the success of breast cancer surgery

byAgency for Science, Technology and Research (A*STAR), SingaporeEquipment set-up. (A) Schematic of the handheld US-OT probe placed in heavy water tank on the specimen. The probe is then moved s

Updated on:December 23,2023 9

Financial toxicity after robotic prostate cancer surgery: Younger patients at higher risk

byWolters Kluwer HealthPatient-reported outcomes measures changes during follow-up for groups (a-d). EF indicates erectile function domain; FT, financial toxicity; ICIQ-SF, International Consult

Updated on: December 25,2023 8

Financial toxicity after robotic prostate cancer surgery: Younger patients at higher risk

byWolters Kluwer HealthPatient-reported outcomes measures changes during follow-up for groups (a-d). EF indicates erectile function domain; FT, financial toxicity; ICIQ-SF, International Consult

Updated on:December 25,2023 8

Trial demonstrates one-year progression-free survival in 94% of patients with stage 3 or 4 classic Hodgkin lymphoma

by SWOG Cancer Research NetworkCredit: Unsplash/CC0 Public DomainA Phase 3 trial has demonstrated that patients with advanced stage (3 or 4) classic Hodgkin lymphoma who underwent initial treatment wi

Updated on: January 04,2024 9

Trial demonstrates one-year progression-free survival in 94% of patients with stage 3 or 4 classic Hodgkin lymphoma

by SWOG Cancer Research NetworkCredit: Unsplash/CC0 Public DomainA Phase 3 trial has demonstrated that patients with advanced stage (3 or 4) classic Hodgkin lymphoma who underwent initial treatment wi

Updated on:January 04,2024 9

Development and application of competing risks and multi-state models in cancer epidemiology

byKarolinska InstitutetCredit: Unsplash/CC0 Public DomainCompeting risks and multi-state models allow us to study complex disease settings and answer composite research questions and should be u

Updated on: December 18,2023 10

Development and application of competing risks and multi-state models in cancer epidemiology

byKarolinska InstitutetCredit: Unsplash/CC0 Public DomainCompeting risks and multi-state models allow us to study complex disease settings and answer composite research questions and should be u

Updated on:December 18,2023 10

Saccharin derivatives give cancer cells a not-so-sweet surprise

byAmerican Chemical SocietyCredit: American Chemical SocietySaccharin received a bad rap after studies in the 1970s linked consumption of large amounts of the artificial sweetener to bladder can

Updated on: December 22,2023 20

Saccharin derivatives give cancer cells a not-so-sweet surprise

byAmerican Chemical SocietyCredit: American Chemical SocietySaccharin received a bad rap after studies in the 1970s linked consumption of large amounts of the artificial sweetener to bladder can

Updated on:December 22,2023 20

Quantitative pathologic analysis may help predict prognosis in colorectal cancer

The quantitative segmentation algorithm (QuantCRC) may improve the prediction of prognosis in colorectal cancer (CRC), according to a study published online Aug. 16 inGastroenterology.Reetesh K.

Updated on: December 20,2023 13

Quantitative pathologic analysis may help predict prognosis in colorectal cancer

The quantitative segmentation algorithm (QuantCRC) may improve the prediction of prognosis in colorectal cancer (CRC), according to a study published online Aug. 16 inGastroenterology.Reetesh K.

Updated on:December 20,2023 13

Curbing blood cancers by teaching immune cells to kill mutant stem cells

by Nancy Fliesler,Children's Hospital BostonROS and TLR3 signaling mediates the "eat-me" and "don't eat me" signals that determine stem cell clonal selection by macro

Updated on: October 24,2024 0

Curbing blood cancers by teaching immune cells to kill mutant stem cells

by Nancy Fliesler,Children's Hospital BostonROS and TLR3 signaling mediates the "eat-me" and "don't eat me" signals that determine stem cell clonal selection by macro

Updated on:October 24,2024 0

Colonoscopy is the most comprehensive screening for colorectal cancer, despite flawed interpretations of a new study

by Franklin G. Berger,The ConversationCredit: American College of GastroenterologyA recently published study in a high-profile medical journal appeared to call into questionthe efficacy of

Updated on: December 26,2023 13

Colonoscopy is the most comprehensive screening for colorectal cancer, despite flawed interpretations of a new study

by Franklin G. Berger,The ConversationCredit: American College of GastroenterologyA recently published study in a high-profile medical journal appeared to call into questionthe efficacy of

Updated on:December 26,2023 13